Anti-pdl1 / VEGF antibodies and methods of use
NI202500057APending Publication Date: 2026-09-28SHANGHAI HENLIUS BIOPHARMACEUTICAL CO LTD +2
0 Cites 0 Cited by
Patent Information
- Application Number
- NI202500057
- Authority / Receiving Office
- NI · NI
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-06-27
- Publication Date
- 2026-09-28
Abstract
This description relates to antibodies and antibody derivatives that bind to PD-L1 and methods of using them. In certain embodiments, the antibody or antibody derivative described herein comprises a single-domain antibody that binds to PD-L1. In certain embodiments, the antibody derivative is a multispecific antibody that binds to PD-L1 and an additional antigen, e.g., VEGF.
Need to check novelty before this filing date? Find Prior Art